Biological disease-modifying anti-rheumatic drugs
Showing 1 - 25 of >10,000
COVID-19 in Rheumatic Inflammatory Diseases Under
Active, not recruiting
- Chronic Inflammatory Rheumatism
- Biological samples
-
Montpellier, Occitanie, FranceCentre hopsitalier universitaire de Montpellier
Jun 10, 2022
Rheumatoid Arthritis Trial (Discontinuation of biological/targeted synthetic disease modifying anti-rheumatic drug (b/tsDMARD))
Not yet recruiting
- Rheumatoid Arthritis
- Discontinuation of biological/targeted synthetic disease modifying anti-rheumatic drug (b/tsDMARD)
- (no location specified)
Nov 12, 2021
Rheumatoid Arthritis Trial in Pondicherry (Methotrexate, Leflunomide, Hydroxychloroquine)
Terminated
- Rheumatoid Arthritis
- Methotrexate
- +5 more
-
Pondicherry, IndiaDepartment of Clinical Immunology , Jawaharlal Institute of Post
Jul 25, 2021
Rheumatoid Arthritis Trial in Singapore (Musculoskeletal ultrasound program)
Completed
- Rheumatoid Arthritis
- Musculoskeletal ultrasound program
-
Singapore, Singapore(unnamed)
Oct 25, 2020
Inhibitors of Jak Kinases in Patients With Rheumatoid Arthritis.
Recruiting
- Arthritis, Rheumatoid
-
Sevilla, SpainHospital Universitario Virgen macarena
Nov 15, 2021
Rheumatoid Arthritis, Spondylitis, Ankylosing, Spondyloarthritis Trial in São Paulo (Recombinant Herpes Zoster Vaccine (RZV),
Recruiting
- Rheumatoid Arthritis
- +9 more
- Recombinant Herpes Zoster Vaccine (RZV)
- +5 more
-
São Paulo, Sao Paulo, BrazilRheumatology Division of Hospital das Clínicas da Faculdade de M
May 24, 2023
Active Polyarticular Juvenile Idiopathic Arthritis Trial in Worldwide (Abatacept)
Active, not recruiting
- Active Polyarticular Juvenile Idiopathic Arthritis
- Abatacept
-
Birmingham, Alabama
- +54 more
Nov 17, 2021
Arthritis, Psoriatic Trial in Worldwide (Placebo matching BMS-945429, BMS-945429)
Completed
- Arthritis, Psoriatic
- Placebo matching BMS-945429
- BMS-945429
-
San Diego, California
- +48 more
Oct 7, 2021
Rheumatic Diseases Trial in Portland (Hepatitis A vaccine, Diphtheria, pertussis, and tetanus booster vaccine)
Recruiting
- Rheumatic Diseases
- Hepatitis A vaccine
- Diphtheria, pertussis, and tetanus booster vaccine
-
Portland, OregonOregon Health & Science University
Sep 14, 2022
Rheumatoid Arthritis Trial in Clermont-Ferrand (Blood test)
Not yet recruiting
- Rheumatoid Arthritis
- Blood test
-
Clermont-Ferrand, FranceCHU Clermont-Ferrand
Sep 20, 2022
Axial Spondyloarthritis, Arthritis, Rheumatoid Trial in Portugal (biological disease-modifying antirheumatic drugs (bDMARDs))
Recruiting
- Axial Spondyloarthritis
- Arthritis, Rheumatoid
- biological disease-modifying antirheumatic drugs (bDMARDs)
-
Aveiro, Portugal
- +9 more
Jul 12, 2021
Moderated to Severe Rheumatoid Arthritis Who Have Failed to
Completed
- Arthritis, Rheumatoid
-
Ilsan, Gyeonggi-do, Korea, Republic of
- +14 more
Dec 14, 2020
Rheumatoid Arthritis Trial ("apigenin" and "glycyrrhizin", "glycyrrhizin" and "boswellic acid", "")
Not yet recruiting
- Rheumatoid Arthritis
- "apigenin" and "glycyrrhizin"
- +2 more
- (no location specified)
Mar 27, 2023
Rheumatoid Arthritis Trial in United States (SAN-300 0.5 mg/kg QW, SAN-300 1.0 mg/kg QW, SAN-300 2.0 mg/kg QOW)
Completed
- Rheumatoid Arthritis
- SAN-300 0.5 mg/kg QW
- +5 more
-
Phoenix, Arizona
- +11 more
Jun 18, 2021
National Data Bank for Rheumatic Disease Registry Study of
Completed
- Rheumatoid Arthritis
- (no location specified)
Jul 15, 2020
Rheumatoid Arthritis (RA) Trial in Brazil, China, Korea, Republic of (Upadacitinib, Placebo)
Completed
- Rheumatoid Arthritis (RA)
- Upadacitinib
- Placebo
-
Curitiba, Parana, Brazil
- +42 more
Aug 30, 2021
Anti-IL-6 Receptor Monoclonal Antibodies on Treatment of
Recruiting
- Rheumatoid Arthritis
- +3 more
-
Barcelona, SpainHospital de la Santa Creu i Sant Pau
Apr 25, 2022
The Norwegian Antirheumatic Drug Register
Recruiting
- Inflammatory Joint Diseases
-
Drammen, Buskerud, Norway
- +5 more
Aug 19, 2022
Rheumatic Disease, HIV, AIDS Trial in São Paulo (CoronaVac)
Active, not recruiting
- Rheumatic Disease
- +5 more
- CoronaVac
-
São Paulo, SP, BrazilUniversity of Sao Paulo General Hospital
May 24, 2022
Predictive Factors for COVID-19 in Rheumatology
Not yet recruiting
- Rheumatic Diseases
- Covid19
- Disease-modifying antirheumatic drugs (DMARDs)
- (no location specified)
Sep 24, 2020
Spondyloarthritis, Rheumatoid Arthritis, Covid19 Trial in Paris (blood tests, Nasopharyngeal swabs, Stools)
Terminated
- Spondyloarthritis
- +2 more
- blood tests
- +2 more
-
Paris, FranceCochin hospital
May 20, 2022